Danielle Antalffy

Stock Analyst at UBS

(0)
# 2510
Out of 3,975 analysts
214
Total ratings
43.69%
Success rate
2.47%
Average return
43 Stocks
Name Action Price Target Current % Upside Ratings Updated
RxSight
Initiates Coverage On: Buy
52
35.67 45.78% 2 Dec 6, 2024
Glaukos
Initiates Coverage On: Buy
182
150.88 20.63% 1 Dec 6, 2024
Sight Sciences
Initiates Coverage On: Buy
6
3.5 57.14% 1 Dec 6, 2024
Stryker
Maintains: Neutral
366 370
361 2.49% 6 Oct 30, 2024
AtriCure
Maintains: Strong Buy
35 40
31.88 25.47% 12 Oct 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
143 146
113.81 28.28% 11 Oct 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
90 75
73.75 1.69% 12 Sep 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
76 90
80.89 11.26% 7 Aug 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
112 107
104.4 2.49% 4 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
7 7
7.91 -11.5% 5 Aug 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
163 95
81.15 17.07% 8 Jul 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
74 90
90.7 -0.77% 10 Apr 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
24 26
17.04 52.58% 3 Feb 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
75
43.2 73.61% 1 Jan 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
180
144.05 24.96% 4 Dec 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
218
n/a n/a 4 Sep 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
405 322
198.07 62.57% 5 Sep 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
3
4.07 -44.72% 1 Mar 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
43
29.45 46.01% 5 Mar 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
278
534.44 -47.98% 1 Mar 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
45
36.74 22.48% 14 Mar 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
160 140
n/a n/a 3 May 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
300 280
264.66 5.8% 12 May 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
65 55
1.41 3800.71% 2 May 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
25 20
n/a n/a 9 May 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
12 14
16.05 -12.77% 1 May 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
75 100
91.07 9.81% 2 May 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 12
11.53 4.08% 3 Mar 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
25 30
84.25 -64.39% 3 Mar 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
60 65
n/a n/a 6 Feb 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
40 45
57.55 -21.81% 4 Feb 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
105 85
3.71 2191.11% 10 Feb 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
85 95
49.94 90.23% 6 Feb 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
270 275
228.45 20.38% 1 Feb 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
345 325
n/a n/a 12 Feb 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Market Perform
36 80
n/a n/a 1 Jan 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
26 20
3.12 541.03% 3 Nov 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
75 66
n/a n/a 4 Nov 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
72 42
9.61 337.04% 7 Nov 5, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
3
0.5 500% 3 Apr 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
15
0.95 1478.95% 1 Sep 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
50 75
n/a n/a 3 Oct 3, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Aug 22, 2017